Zimmer Biomet 

CHF92.99
138
+CHF0+0% 今天

統計

當日最高
93.43
當日最低
92.51
52週最高
-
52週最低
-
成交量
192.07
平均成交量
-
市值
-
市盈率
-
股息收益率
0.93%
股息
0.86

即將到來

股息

0.93%股息收益率
10年增長
0.56%
5年增長率
-1.82%
3年增長率
-1.03%
1年增長率
0.26%

收益

31Oct確認
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
下一個
1.6
1.8
2
2.2
預期每股收益
1.806206
實際每股收益
N/A

人們還關注

此列表基於在 Stock Events 上關注 0QQD.LSE 的人的關注列表。這不是投資建議。

競爭者

這個列表是基於最近市場事件的分析。這不是投資建議。

關於

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest toss facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as robotic, surgical and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
Show more...
首席執行官
Mr. Bryan C. Hanson
員工
19500
國家
United States
ISIN
US98956P1021
WKN
000753718

上市公司